Find a Research Lab

Physician-researcher Pamela Becker, M.D., Ph.D., is a highly respected clinician with expertise in acute myeloid leukemia, multiple myeloma, bone marrow failure and other diseases of the blood and immune system, as well as a leader in studies to translate research breakthroughs into health solutions and to improve therapy for blood cancers. 

Our group uses state-of-the-art technologies in basic and translational research to gain new insights potentially leading to improved outcomes for patients with cancer. 

The Annabel Wang studies the development of fat cells — in particular the ones that make up white adipose tissue. Learn about our latest research.

Rui Su Lab in the Department of Systems Biology mainly focuses on delineating the biological functions and underlying mechanisms of RNA modifications and RNA-binding proteins (RBPs) in tumorigenesis.

The overall goal of the research in the Vasavada laboratory is to understand the pathophysiology of type 1 and type 2 diabetes and identify therapeutics for its treatment

Research in the Dhawan laboratory is focused on understanding the mechanisms of the growth and maintenance of pancreatic beta cells to identify novel therapeutic targets for the prevention and reversal of beta cell dysfunction and loss in diabetes. 

The Sarah Shuck Lab is investigating the biochemistry involved when excess sugar damages important molecules such as proteins and DNA.

The Priceman Lab research program develops chimeric antigen receptor (CAR)-based T cell immunotherapy for the treatment of solid tumors at City of Hope.

Dr. Swaminathan’s studies suggest that NK cells can be developed as an adoptive cell-based immunotherapy against MYC and other oncogene-driven lymphomas.

Our translational genomics laboratory leverages cancer care delivery, health communication and informatics methods to improve access to precision oncology and optimize patient outcomes.